ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 124 filers reported holding ANIKA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $259,330 | +5.0% | 13,920 | +46.4% | 0.00% | 0.0% |
| Q2 2023 | $247,070 | -11.4% | 9,510 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $278,871 | -12.0% | 9,710 | -9.3% | 0.00% | -50.0% |
| Q4 2022 | $317,016 | -44.4% | 10,710 | -55.3% | 0.00% | -33.3% |
| Q3 2022 | $570,000 | +13.5% | 23,960 | +6.6% | 0.00% | +50.0% |
| Q2 2022 | $502,000 | -14.5% | 22,470 | -3.9% | 0.00% | 0.0% |
| Q1 2022 | $587,000 | -51.4% | 23,385 | -30.6% | 0.00% | -60.0% |
| Q4 2021 | $1,208,000 | -24.5% | 33,717 | -10.2% | 0.01% | -28.6% |
| Q3 2021 | $1,599,000 | -8.2% | 37,562 | -6.6% | 0.01% | -12.5% |
| Q2 2021 | $1,741,000 | -19.3% | 40,222 | -23.9% | 0.01% | -20.0% |
| Q1 2021 | $2,157,000 | -30.6% | 52,877 | -23.0% | 0.01% | -23.1% |
| Q4 2020 | $3,109,000 | +2.5% | 68,688 | -19.8% | 0.01% | -7.1% |
| Q3 2020 | $3,032,000 | -23.5% | 85,680 | -18.4% | 0.01% | -26.3% |
| Q2 2020 | $3,961,000 | +40.9% | 104,971 | +7.9% | 0.02% | +5.6% |
| Q1 2020 | $2,812,000 | +622.9% | 97,276 | +1197.5% | 0.02% | +800.0% |
| Q4 2019 | $389,000 | +9.6% | 7,497 | +15.9% | 0.00% | 0.0% |
| Q3 2019 | $355,000 | -2.2% | 6,467 | -46.2% | 0.00% | 0.0% |
| Q1 2019 | $363,000 | -33.6% | 12,016 | -26.2% | 0.00% | -33.3% |
| Q4 2018 | $547,000 | -20.4% | 16,286 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $687,000 | -8.3% | 16,286 | -30.4% | 0.00% | 0.0% |
| Q2 2018 | $749,000 | -35.9% | 23,395 | -0.4% | 0.00% | -42.9% |
| Q1 2018 | $1,168,000 | -34.1% | 23,495 | -28.5% | 0.01% | -30.0% |
| Q4 2017 | $1,773,000 | +38.5% | 32,880 | +48.9% | 0.01% | +42.9% |
| Q3 2017 | $1,280,000 | +28.5% | 22,076 | +9.4% | 0.01% | +16.7% |
| Q2 2017 | $996,000 | +14.1% | 20,186 | +0.5% | 0.01% | 0.0% |
| Q1 2017 | $873,000 | -27.8% | 20,086 | -18.7% | 0.01% | -33.3% |
| Q4 2016 | $1,209,000 | +52.3% | 24,697 | +48.8% | 0.01% | +28.6% |
| Q3 2016 | $794,000 | -10.8% | 16,597 | 0.0% | 0.01% | -12.5% |
| Q2 2016 | $890,000 | -10.6% | 16,597 | -25.5% | 0.01% | -11.1% |
| Q1 2016 | $996,000 | -5.2% | 22,265 | -19.2% | 0.01% | -10.0% |
| Q4 2015 | $1,051,000 | +63.5% | 27,545 | +36.3% | 0.01% | +66.7% |
| Q3 2015 | $643,000 | -3.6% | 20,205 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $667,000 | -16.0% | 20,205 | +4.8% | 0.01% | -14.3% |
| Q1 2015 | $794,000 | -4.0% | 19,285 | -5.0% | 0.01% | -12.5% |
| Q4 2014 | $827,000 | +77.1% | 20,295 | +59.3% | 0.01% | +33.3% |
| Q3 2014 | $467,000 | – | 12,740 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
| CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
| Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
| DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
| Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
| Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
| Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
| Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
| CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
| Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |